Malteser Krankenhaus St. Hildegardis
Koln, Germany
Emergency room in Cologne, North Rhine-Westphalia
Bachemer Str. 29-33, 50931 Köln
About Malteser Krankenhaus St. Hildegardis
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Malteser Krankenhaus St. Hildegardis
During the past decade, Malteser Krankenhaus St. Hildegardis conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
SWOG-9430: Surgery in Treating Patients With Metastatic Melanoma
1996-11-01
2010-12-01
Completed
77
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma
1998-11-01
2011-07-01
Completed
29
High-Dose Interferon Alfa in Treating Patients With Stage II or Stage III Melanoma
1998-12-01
2025-10-01
Active, not recruiting
1,150
S0012 Doxorubicin, Cyclophosphamide, and Paclitaxel With or Without Filgrastim in Treating Women With Inflammatory or Locally Advanced Breast Cancer
2001-05-01
2012-02-01
Completed
399
Surgery Versus Internal Radiation in Treating Patients With Stage II Prostate Cancer
2001-10-01
2004-04-01
Completed
190
Radiosurgery With or Without Whole-Brain Radiation Therapy in Treating Patients With Brain Metastases
2001-12-01
2014-10-01
Completed
480
S0215 Trastuzumab, Docetaxel, Vinorelbine, and Filgrastim in Treating Women With Stage IV Breast Cancer
2002-09-01
2012-01-01
Completed
76
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Malteser Krankenhaus St. Hildegardis"
#1 collaborator was "CRI-The Clinical Research Institute GmbH" with 1 trials as a collaborator and "Roche Pharma AG" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Malteser Krankenhaus St. Hildegardis
According to Clinical.Site data, the most researched conditions in "Malteser Krankenhaus St. Hildegardis" are
"Heart Failure" (2 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Cheyne Stokes Respiration" (1 trials), "Congestive Heart Failure" (1 trials) and "Left Ventricular Systolic Dysfunction" (1 trials). Many other conditions were trialed in "Malteser Krankenhaus St. Hildegardis" in a lesser frequency.
Clinical Trials Intervention Types at Malteser Krankenhaus St. Hildegardis
Most popular intervention types in "Malteser Krankenhaus St. Hildegardis" are "Device" (2 trials) and "Drug" (1 trials). Other intervention types were less common.
The name of intervention was led by "Bevacizumab" (1 trials), "Cisplatin" (1 trials), "Erlotinib" (1 trials), "Europe: AutoSet CS (USA: VPAP Adapt SV)" (1 trials) and "Gemcitabine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Malteser Krankenhaus St. Hildegardis
The vast majority of trials in "Malteser Krankenhaus St. Hildegardis" are
4 trials for "All" genders.
Clinical Trials Status at Malteser Krankenhaus St. Hildegardis
Currently, there are NaN active trials in "Malteser Krankenhaus St. Hildegardis".
undefined are not yet recruiting,
undefined are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Malteser Krankenhaus St. Hildegardis,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Malteser Krankenhaus St. Hildegardis, 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 1 trials that are defined as “Not Applicable".